search
Back to results

Feasibility Study of Balloon Kyphoplasty in Traumatic Vertebral Fractures Needing Surgical Fixation (TRAUMAA3B1C1)

Primary Purpose

One or Two Traumatic Vertebral Fractures, Located Between T11 and L5, Balloon Kyphoplasty

Status
Terminated
Phase
Phase 4
Locations
France
Study Type
Interventional
Intervention
balloon kyphoplasty
Sponsored by
Assistance Publique - Hôpitaux de Paris
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for One or Two Traumatic Vertebral Fractures focused on measuring Traumatic vertebral fracture, Balloon Kyphoplasty, type A3.2, or A3.3 or B1 or C1 in the MAGERL CLASSIFICATION

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Preliminary clinical examination (the anaesthesist must have provided his approval for the surgical procedure)
  • Patient must have signed the consent form
  • Male or female patient aged 18 or over
  • One or two traumatic vertebral fractures located between T11 and L5 and type A3.2, A3.3, B1 or C1 in the MAGERL classification, and with a regional kyphotic angle > 15° and treated by osteosynthesis through a posterior surgical approach with or without spinal decompression
  • Fracture with or without neurological difficulties
  • Non tumoral origin: Confirmed by biopsy at the same time of the Balloon Kyphoplasty procedure.

Exclusion Criteria:

  • Non- traumatic, malignant or osteoporotic vertebral fractures
  • History of surgical or percutaneous spine treatment except simple discectomy at a single or multiple vertebral levels with no residual pain.
  • Known allergy to a contrast media or to one of the cement components used for kyphoplasty.
  • More than two recent vertebral fractures
  • Current infection
  • Impossibility to perform the percutaneous approach of the vertebra to treat.
  • Reduction by more than 50% of the anteroposterior width of the bony spinal canal due to the vertebral fracture to treat.
  • Vertebral fracture with loss of 90%or more of the vertebral body height
  • Patient presenting a non correctable spontaneous or therapeutic coagulation disorder.
  • Evolutive cardiac disease nonreactive to medical treatment
  • Non compliant patient: Impossibility to participate to the study and to be followed up for 1 year.
  • Pregnant or breast feeding women
  • Patient not affiliated to social security

Sites / Locations

  • Service de Radiologie, Hôpital Lariboisière

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

1

Arm Description

Balloon kyphoplasty

Outcomes

Primary Outcome Measures

Loss of less than 10 degrees in spine kyphosis angle at one year follow-up after surgery compared to postoperative measurements

Secondary Outcome Measures

Pain evaluation using a visual analogic scale
EIFEL questionnaire for back pain evaluation
Quality of life evaluation (SF 12).
Analgesics intake according to the WHO classification (Classes 1, 2 and 3).
Regional spine Kyphosis angle and global thoracic and lumbar Kyphosis angle.
Changes in anterior, mid and posterior vertebral heights of the treated vertebral body
Changes in height of the intervertebral disc spaces adjacent to the treated vertebra.
Number of new vertebral fractures occurring during the one year follow-up period.
Cost evaluation in a sample of 10% of patients randomly selected including the following costs : o Intervention cost.o Medical treatment costs o Consultation costs. o Hospitalization cost o Complication costs
Follow-up of anterior, median and posterior height of the treated vertebral body, obtained by making an average of all measurements, on 3 cuts tomodensitometry (TDM) on the sagittal level : lateral right, median and lateral left

Full Information

First Posted
September 8, 2008
Last Updated
January 3, 2017
Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
Ministry of Health, France
search

1. Study Identification

Unique Protocol Identification Number
NCT00749229
Brief Title
Feasibility Study of Balloon Kyphoplasty in Traumatic Vertebral Fractures Needing Surgical Fixation
Acronym
TRAUMAA3B1C1
Official Title
Prospective Cohort Study on the Feasibility and Reliability of 'Open' Balloon Kyphoplasty in Types A3.2, A3.3, B1 and C1 MAGERL Classification Vertebral Fractures(STIC 4)
Study Type
Interventional

2. Study Status

Record Verification Date
December 2014
Overall Recruitment Status
Terminated
Why Stopped
the number of patients recruited at present is sufficient for analysis.
Study Start Date
December 2007 (undefined)
Primary Completion Date
March 2011 (Actual)
Study Completion Date
March 2011 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
Ministry of Health, France

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Some unstable traumatic vertebral fractures (types A3.2, A3.3, B1 et C1 according to MAGERL classification) may undergo unpredictable secondary displacement. Such fractures require a two session surgery with a first operation carried out immediately to achieve posterior fixation and a second surgery which is performed some days later to stabilize the anterior spine and restore stress resistance. Goal of the present study is to show that percutaneous Balloon Kyphoplasty is able to restore anterior spine strength and replace second session surgery.
Detailed Description
Patients with traumatic vertebral fractures type A3.2, A3.3, B1 and C1 of the MAGERL classification will be enrolled in this open study. They will be operated on in emergency to perform spinal canal decompression, fracture reduction and posterior fixation using fixation plates with pedicular screws combined with bone graft. During the same surgery or some days later on, percutaneous Balloon kyphoplasty of the fractured vertebral body (ies) using polymethylmetacrylate cement injection through a posterior transpedicular approach will be carried out in replacement of anterior spine surgery to restore vertebral body strength.Patients will be followed up for one year. Expected advantages of this management compared the conventional two session surgery include the following: decreased morbidity due to suppression of the anterior surgery improve final spine alignment and vertebral Kyphotic angle avoiding the loss in kyphotic angle which often occurs between the posterior and anterior surgery with the conventional two session surgery.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
One or Two Traumatic Vertebral Fractures, Located Between T11 and L5, Balloon Kyphoplasty
Keywords
Traumatic vertebral fracture, Balloon Kyphoplasty, type A3.2, or A3.3 or B1 or C1 in the MAGERL CLASSIFICATION

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 4
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
17 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Other
Arm Description
Balloon kyphoplasty
Intervention Type
Device
Intervention Name(s)
balloon kyphoplasty
Intervention Description
During the same surgery or some days later on, percutaneous Balloon kyphoplasty of the fractured vertebral body (ies) using polymethylmetacrylate cement injection through a posterior transpedicular approach will be carried out in replacement of anterior spine surgery to restore vertebral body strength
Primary Outcome Measure Information:
Title
Loss of less than 10 degrees in spine kyphosis angle at one year follow-up after surgery compared to postoperative measurements
Time Frame
1 year
Secondary Outcome Measure Information:
Title
Pain evaluation using a visual analogic scale
Time Frame
J-20 to J-7 - J6 - J45 - J90 - J180 - J360
Title
EIFEL questionnaire for back pain evaluation
Time Frame
J-20 to J-7 - J6 - J45 - J90 - J180 - J360
Title
Quality of life evaluation (SF 12).
Time Frame
J-20 to J-7 - J6 - J45 - J90 - J180 - J360
Title
Analgesics intake according to the WHO classification (Classes 1, 2 and 3).
Time Frame
J-20 to J-7 - J6 - J45 - J90 - J180 - J360
Title
Regional spine Kyphosis angle and global thoracic and lumbar Kyphosis angle.
Time Frame
J-20 to J-7 - J6 - J45 - J90 - J180 - J360
Title
Changes in anterior, mid and posterior vertebral heights of the treated vertebral body
Time Frame
J-20 to J-7 - J6 - J45 - J90 - J180 - J360
Title
Changes in height of the intervertebral disc spaces adjacent to the treated vertebra.
Time Frame
J-20 to J-7 - J6 - J45 - J90 - J180 - J360
Title
Number of new vertebral fractures occurring during the one year follow-up period.
Time Frame
J-20 to J-7 - J6 - J45 - J90 - J180 - J360
Title
Cost evaluation in a sample of 10% of patients randomly selected including the following costs : o Intervention cost.o Medical treatment costs o Consultation costs. o Hospitalization cost o Complication costs
Time Frame
J-20 to J-7 - J6 - J45 - J90 - J180 - J360
Title
Follow-up of anterior, median and posterior height of the treated vertebral body, obtained by making an average of all measurements, on 3 cuts tomodensitometry (TDM) on the sagittal level : lateral right, median and lateral left
Time Frame
preoperative, at J6 and at J360

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Preliminary clinical examination (the anaesthesist must have provided his approval for the surgical procedure) Patient must have signed the consent form Male or female patient aged 18 or over One or two traumatic vertebral fractures located between T11 and L5 and type A3.2, A3.3, B1 or C1 in the MAGERL classification, and with a regional kyphotic angle > 15° and treated by osteosynthesis through a posterior surgical approach with or without spinal decompression Fracture with or without neurological difficulties Non tumoral origin: Confirmed by biopsy at the same time of the Balloon Kyphoplasty procedure. Exclusion Criteria: Non- traumatic, malignant or osteoporotic vertebral fractures History of surgical or percutaneous spine treatment except simple discectomy at a single or multiple vertebral levels with no residual pain. Known allergy to a contrast media or to one of the cement components used for kyphoplasty. More than two recent vertebral fractures Current infection Impossibility to perform the percutaneous approach of the vertebra to treat. Reduction by more than 50% of the anteroposterior width of the bony spinal canal due to the vertebral fracture to treat. Vertebral fracture with loss of 90%or more of the vertebral body height Patient presenting a non correctable spontaneous or therapeutic coagulation disorder. Evolutive cardiac disease nonreactive to medical treatment Non compliant patient: Impossibility to participate to the study and to be followed up for 1 year. Pregnant or breast feeding women Patient not affiliated to social security
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jean-Denis LAREDO, M.D.,PR.
Organizational Affiliation
AP/HP Assistance Publique-Hôpitaux de Paris
Official's Role
Principal Investigator
Facility Information:
Facility Name
Service de Radiologie, Hôpital Lariboisière
City
Paris
ZIP/Postal Code
75010
Country
France

12. IPD Sharing Statement

Learn more about this trial

Feasibility Study of Balloon Kyphoplasty in Traumatic Vertebral Fractures Needing Surgical Fixation

We'll reach out to this number within 24 hrs